-+ 0.00%
-+ 0.00%
-+ 0.00%

Tevogen Bio gets Nasdaq notice for failing $50 million market value requirement

PUBT·04/22/2026 21:16:12
Listen to the news
Tevogen Bio gets Nasdaq notice for failing $50 million market value requirement
  • Nasdaq warned Tevogen Bio failed to meet continued-listing thresholds tied to market value.
  • Letter dated April 16, 2026 cited market value of listed securities below USD 50 million for 30 consecutive business days.
  • Second notice dated April 17, 2026 cited market value of publicly held shares below USD 15 million for 30 consecutive business days.
  • Nasdaq set compliance deadlines of Oct. 13, 2026 for MVLS requirement, Oct. 14, 2026 for MVPHS requirement.
  • Tevogen Bio may pursue steps to regain compliance, including evaluating a transfer to Nasdaq Capital Market.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-018590), on April 22, 2026, and is solely responsible for the information contained therein.